What Are Best Risk Stratification Tools When Placing Patient on Active Surveillance?

Posted by Laurence Klotz, MD, FRCSC | Oct 2017

Laurence Klotz, MD, Sunnybrook Health Sciences Centre, Toronto, Ontario, discusses the types of risk stratification tools doctors can use when placing a patient on active surveillance.

Interview produced by Prostatepedia

Keywords: risk stratification tools, active surveillance, prostate cancer

About The Author

Laurence Klotz, MD, FRCSC

Laurence Klotz, MD, FRCSC, is a professor of surgery at the University of Toronto and the Sunnybrook Chair of Prostate Cancer Research. Dr. Klotz was the founding editor-in-chief of both the Canadian Journal of Urology and the Canadian Urology Association Journal (CUAJ), and he is now editor emeritus of the CUAJ. Dr. Klotz obtained his medical degree and completed his residency at the University of Toronto. He was also a uro-oncology fellow at Memorial Sloan Kettering Cancer Center in New York. Dr. Klotz has 550 peer review publications and eight books. He coined the phrase “active surveillance” and successfully championed this approach for men with favorable-risk prostate cancer against substantial resistance. He was the associate editor of the Journal of Urology, responsible for prostate cancer, for eight years. Dr. Klotz received the Queen’s Jubilee Medal for outstanding public service, the University of Toronto's Lister Prize, the Society of Urologic Oncology’s SUO Medal, the American Urological Association’s Richard Williams Award, the University of Toronto's Lifetime Achievement Award, the Canadian Urological Association Lifetime Achievement Award, and the Harold Warwick Award from the Canadian Cancer Society for “outstanding contributions to cancer control.” In 2015 he was inducted as a Member of the Order of Canada, Canada’s highest civilian award.

Join the GRU Community

- Why Join? -

Share This

Chat with usLiveChat